Laboratory Medicine and Nosocomial infections: Solutions in the Pipeline
|
By LabMedica International staff writers Posted on 25 Feb 2010 |
On the horizon is technology from the molecular diagnostic company Great Basin Scientific (Salt Lake City, UT, USA). The company's technology is designed to improve the traditional methods of diagnostic testing of hospital-acquired infections, such as methicillin-resistant Staphylococcus aureus (MRSA), allowing test results to come back in less than an hour versus the traditional one- to two-day waiting period.
Great Basin Scientific's silicon chip-based technology is simple, cost-effective, and better than the highly complex, traditional polymerase chain reaction (PCR) method that requires the skills of highly trained technicians and sometimes even multiple rooms to avoid cross contamination of tests. The company's sensitive, easy-to-use integrated cartridge system, which can be performed in a clinical laboratory improved amendments (CLIA)-rated moderately complex or waived laboratory, will give health care providers and their patients the benefit of point-of-care test results within a 20- to 60-minute time frame at costs much lower than current molecular solutions.
In the past two decades, one of the most important discoveries to come out of the microbiology world is the fact that bacteria can communicate. They are able converse on a level where they can induce each other to switch on dormant genes that then have the capacity to do harm.
The superbug methicillin-resistant Staphylococcus aureus (MRSA) is part of this phenomenon, called "quorum sensing.” Quorum sensing is the ability of bacteria to communicate and coordinate behavior using signaling molecules called autoinducers. Autoinducers are continuously produced by bacteria but when their concentration reaches a certain threshold--that is, when the bacteria producing it have a quorum--they switch on transcription genes within the bacteria's DNA telling it to do two things: to produce more autoinducer and, crucially, to change behavior.
Once a biofilm is established it is very difficult to get rid of as can be witnessed by the ubiquity of dental plaque and dogged resistance of MRSA to treatment. There have been attempts to solve this problem with some promising results. For example, Jong-Chul Park at the Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine (Seoul, Korea) and colleagues reported that they were able to rapidly remove biofilms and planktonic bacteria on glass by using microwave-induced argon plasma at atmospheric pressure. Their work was published on November 28, 2009 in the New Journal of Physics.
Related Links:
Great Basin Scientific
Yonsei University College of Medicine
Great Basin Scientific's silicon chip-based technology is simple, cost-effective, and better than the highly complex, traditional polymerase chain reaction (PCR) method that requires the skills of highly trained technicians and sometimes even multiple rooms to avoid cross contamination of tests. The company's sensitive, easy-to-use integrated cartridge system, which can be performed in a clinical laboratory improved amendments (CLIA)-rated moderately complex or waived laboratory, will give health care providers and their patients the benefit of point-of-care test results within a 20- to 60-minute time frame at costs much lower than current molecular solutions.
In the past two decades, one of the most important discoveries to come out of the microbiology world is the fact that bacteria can communicate. They are able converse on a level where they can induce each other to switch on dormant genes that then have the capacity to do harm.
The superbug methicillin-resistant Staphylococcus aureus (MRSA) is part of this phenomenon, called "quorum sensing.” Quorum sensing is the ability of bacteria to communicate and coordinate behavior using signaling molecules called autoinducers. Autoinducers are continuously produced by bacteria but when their concentration reaches a certain threshold--that is, when the bacteria producing it have a quorum--they switch on transcription genes within the bacteria's DNA telling it to do two things: to produce more autoinducer and, crucially, to change behavior.
Once a biofilm is established it is very difficult to get rid of as can be witnessed by the ubiquity of dental plaque and dogged resistance of MRSA to treatment. There have been attempts to solve this problem with some promising results. For example, Jong-Chul Park at the Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine (Seoul, Korea) and colleagues reported that they were able to rapidly remove biofilms and planktonic bacteria on glass by using microwave-induced argon plasma at atmospheric pressure. Their work was published on November 28, 2009 in the New Journal of Physics.
Related Links:
Great Basin Scientific
Yonsei University College of Medicine
Latest Microbiology News
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
- Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
- Study Finds Hidden Mpox Infections May Drive Ongoing Spread
- Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
- Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
- Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
- Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria
- Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
- Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
- Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections
- Antibiotic Resistance Genes Found in Newborns Within Hours of Birth
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more








